Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024
Coherus BioSciences (NASDAQ: CHRS) has announced it will release its third quarter 2024 financial results after market close on Wednesday, November 6, 2024. The company's management will host a conference call and webcast at 5:00 p.m. ET on the same day to discuss the results and provide a business update. Investors can access the conference call through pre-registration and join the webcast through the company's investor relations website. The financial results press release and related materials will be available before the call on the Coherus investor website.
Coherus BioSciences (NASDAQ: CHRS) ha annunciato che pubblicherà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato mercoledì 6 novembre 2024. La direzione dell'azienda ospiterà una teleconferenza e una trasmissione in webcast alle 17:00 ET lo stesso giorno per discutere i risultati e fornire un aggiornamento aziendale. Gli investitori possono accedere alla teleconferenza tramite registrazione anticipata e unirsi alla trasmissione in webcast attraverso il sito web delle relazioni con gli investitori della società. Il comunicato stampa sui risultati finanziari e i materiali correlati saranno disponibili prima della chiamata sul sito degli investitori di Coherus.
Coherus BioSciences (NASDAQ: CHRS) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el miércoles 6 de noviembre de 2024. La dirección de la empresa celebrará una conferencia telefónica y un webcast a las 5:00 p.m. ET el mismo día para discutir los resultados y proporcionar una actualización sobre el negocio. Los inversores pueden acceder a la conferencia telefónica mediante preinscripción y unirse al webcast a través del sitio web de relaciones con inversores de la empresa. El comunicado de prensa de los resultados financieros y los materiales relacionados estarán disponibles antes de la llamada en el sitio de inversores de Coherus.
Coherus BioSciences (NASDAQ: CHRS)는 2024년 11월 6일 수요일 거래 종료 후 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사 경영진은 같은 날 오후 5:00 ET에 결과를 논의하고 사업 업데이트를 제공하기 위해 컨퍼런스 콜 및 웹캐스트를 진행합니다. 투자자들은 사전 등록을 통해 컨퍼런스 콜에 접근할 수 있으며, 회사의 투자자 관계 웹사이트를 통해 웹캐스트에 참여할 수 있습니다. 재무 결과의 보도 자료 및 관련 자료는 콜 전에 Coherus 투자자 웹사이트에서 확인할 수 있습니다.
Coherus BioSciences (NASDAQ: CHRS) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 après la clôture du marché le mercredi 6 novembre 2024. La direction de l'entreprise organisera une conférence téléphonique et un webinaire à 17h00 ET le même jour pour discuter des résultats et fournir une mise à jour sur l'activité. Les investisseurs peuvent accéder à la conférence téléphonique par préinscription et rejoindre le webinaire via le site web des relations avec les investisseurs de l'entreprise. Le communiqué de presse des résultats financiers et les documents connexes seront disponibles avant l'appel sur le site des investisseurs de Coherus.
Coherus BioSciences (NASDAQ: CHRS) hat bekannt gegeben, dass die Finanzergebnisse für das dritte Quartal 2024 nach Handelsschluss am Mittwoch, den 6. November 2024, veröffentlicht werden. Die Unternehmensleitung wird am selben Tag um 17:00 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und ein Update zum Geschäft zu geben. Investoren können über eine Voranmeldung auf die Telefonkonferenz zugreifen und über die Investoren-Website des Unternehmens am Webcast teilnehmen. Die Pressemitteilung zu den Finanzergebnissen und die dazugehörigen Materialien werden vor dem Anruf auf der Coherus-Investoren-Website verfügbar sein.
- None.
- None.
REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its third quarter 2024 financial results will be released after market close on Wednesday, November 6, 2024. Starting at 5:00 p.m. ET on November 6, 2024, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
A webcast replay will be available on https://investors.coherus.com following the conclusion of the live conference call.
Conference Call Information
When: Wednesday, November 6, 2024, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI6dfb4eba6e9a4322a716df863233a53f
Webcast: https://edge.media-server.com/mmc/p/fgk872yp
The press release with the third quarter 2024 financial results and related materials will be available at https://investors.coherus.com before the start of the conference call.
A live and archived webcast will be available on the “Investors” section of the Coherus website at https://investors.coherus.com/events-presentations.
Please dial in 15 minutes early to ensure a timely connection to the call.
Disclosure Information
Coherus uses the https://investors.coherus.com website to disclose material non-public information and comply with its disclosure obligations under Regulation FD.
Coherus Contact Information
Investors:
Jodi Sievers, Vice President, Investor Relations and Corporate Communications
IR@coherus.com
FAQ
When will Coherus BioSciences (CHRS) release Q3 2024 earnings?
What time is the Coherus BioSciences (CHRS) Q3 2024 earnings call?
How can investors access the Coherus BioSciences (CHRS) Q3 2024 earnings call?
